CN109692293A - The drug for treating cerebrovascular sclerosis - Google Patents

The drug for treating cerebrovascular sclerosis Download PDF

Info

Publication number
CN109692293A
CN109692293A CN201710989235.1A CN201710989235A CN109692293A CN 109692293 A CN109692293 A CN 109692293A CN 201710989235 A CN201710989235 A CN 201710989235A CN 109692293 A CN109692293 A CN 109692293A
Authority
CN
China
Prior art keywords
drug
cerebrovascular sclerosis
treating cerebrovascular
treating
sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710989235.1A
Other languages
Chinese (zh)
Inventor
焦雁琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710989235.1A priority Critical patent/CN109692293A/en
Publication of CN109692293A publication Critical patent/CN109692293A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8965Asparagus, e.g. garden asparagus or asparagus fern
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9062Alpinia, e.g. red ginger or galangal

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a kind of drug for treating cerebrovascular sclerosis, consists of the following compositions: root of three-nerved spicebush 10g-20g, cortex cinnamomi 10g-20g, galanga 10g-20g, Radix Codonopsis 10g-20g, gold boiling grass 10g-20g, fimbriatestipulate begonia herb 10g-20g, nettle 10g-20g, beggar-ticks 10g-20g, herba fibraureae recisae 10g-20g and asparagus fern 10g-20g.The beneficial effects of the present invention are: cerebrovascular sclerosis can be effectively treated, quick, crowd that is without side-effects and being suitable for each age group and different sexes.

Description

The drug for treating cerebrovascular sclerosis
Technical field
The invention belongs to drug fields, and in particular to a kind of drug for treating cerebrovascular sclerosis.
Background technique
Cerebrovascular sclerosis is a kind of common, multiple and all age group, the symptom that men and women, old and young can occur.Currently, In the presence of the drug of many treatment cerebrovascular sclerosis, but the not so good and many drug of curative effect can generate certain secondary work mostly With.With the development of society, these drugs are no longer satisfied disease Man's Demands.
Summary of the invention
The technical problems to be solved by the invention are in view of the above shortcomings of the prior art, to provide and a kind of treat the cerebrovascular The drug of hardening can easily treat cerebrovascular sclerosis and without side-effects.
The technical scheme adopted by the invention is that: a kind of drug for treating cerebrovascular sclerosis consists of the following compositions:
Root of three-nerved spicebush 10g-20g, cortex cinnamomi 10g-20g, galanga 10g-20g, Radix Codonopsis 10g-20g, gold boiling grass 10g-20g, fimbriatestipulate begonia herb 10g- 20g, nettle 10g-20g, beggar-ticks 10g-20g, herba fibraureae recisae 10g-20g and asparagus fern 10g-20g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: cerebrovascular sclerosis can be effectively treated, it is quick, it is without side-effects and be suitable for each The crowd of age bracket and different sexes.
Specific embodiment
Below in conjunction with specific embodiment, invention is further described in detail.
A kind of drug for treating cerebrovascular sclerosis, consists of the following compositions:
Root of three-nerved spicebush 10g-20g, cortex cinnamomi 10g-20g, galanga 10g-20g, Radix Codonopsis 10g-20g, gold boiling grass 10g-20g, fimbriatestipulate begonia herb 10g- 20g, nettle 10g-20g, beggar-ticks 10g-20g, herba fibraureae recisae 10g-20g and asparagus fern 10g-20g.
Preferably, described drug can be made into decoction.
Preferably, described drug can be made into tablet.
Preferably, described drug can be made into capsule.
The beneficial effects of the present invention are: cerebrovascular sclerosis can be effectively treated, it is quick, it is without side-effects and be suitable for each The crowd of age bracket and different sexes.

Claims (4)

1. a kind of drug for treating cerebrovascular sclerosis, it is characterised in that: consist of the following compositions:
Root of three-nerved spicebush 10g-20g, cortex cinnamomi 10g-20g, galanga 10g-20g, Radix Codonopsis 10g-20g, gold boiling grass 10g-20g, fimbriatestipulate begonia herb 10g- 20g, nettle 10g-20g, beggar-ticks 10g-20g, herba fibraureae recisae 10g-20g and asparagus fern 10g-20g.
2. a kind of drug for treating cerebrovascular sclerosis according to claim 1, it is characterised in that: described drug can be made into Decoction.
3. a kind of drug for treating cerebrovascular sclerosis according to claim 1, it is characterised in that: described drug can be made into Tablet.
4. a kind of drug for treating cerebrovascular sclerosis according to claim 1, it is characterised in that: described drug can be made into Capsule.
CN201710989235.1A 2017-10-22 2017-10-22 The drug for treating cerebrovascular sclerosis Pending CN109692293A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710989235.1A CN109692293A (en) 2017-10-22 2017-10-22 The drug for treating cerebrovascular sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710989235.1A CN109692293A (en) 2017-10-22 2017-10-22 The drug for treating cerebrovascular sclerosis

Publications (1)

Publication Number Publication Date
CN109692293A true CN109692293A (en) 2019-04-30

Family

ID=66225809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710989235.1A Pending CN109692293A (en) 2017-10-22 2017-10-22 The drug for treating cerebrovascular sclerosis

Country Status (1)

Country Link
CN (1) CN109692293A (en)

Similar Documents

Publication Publication Date Title
CN109692293A (en) The drug for treating cerebrovascular sclerosis
CN1883642A (en) Medicine for treating mammary glands hyperplasia
CN103055055A (en) Traditional Chinese medicine for treating skin diseases
CN109419918A (en) A kind of drug for treating hemorrhoid
CN104491072A (en) Traditional Chinese medicine for treating nerve-root type cervical spondylosis
CN109692268A (en) The drug for treating multiple sclerosis
CN109420102A (en) A kind of drug for treating gastritis
CN109419873A (en) A kind of drug for treating gastrorrhagia
CN109692295A (en) The drug for treating cold
CN109692287A (en) The drug for treating dermatitis
CN109692246A (en) A kind of drug for treating motor neuron disease
CN100350950C (en) Wuzishan Chinese medicines for cancer pains
CN109692260A (en) A kind of drug for treating primary aldosteronism
CN101983645A (en) Medicament for treating acute appendicitis
CN101979073A (en) Medicament for soothing liver and regulating Qi
CN109692297A (en) The drug for treating tinea of feet and hands
CN109692218A (en) The drug for treating chronic cor pulmonale
CN109419861A (en) A kind of drug for treating tympanitis
CN109692299A (en) A kind of drug for treating diabetes
CN102018917A (en) Traditional Chinese medicine pill for treating various polypi
CN1879778A (en) Headache-treating medicine
CN109692275A (en) The drug for treating hyperthyroid heart disease
CN109420056A (en) A kind of drug for treating toothache
CN105770628A (en) Traditional Chinese medicine for treating psoriasis
CN109692296A (en) Treat neuralgic drug

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190430